Hines, Ronald N

Human Hepatic Flavin-Containing Monooxygenases 1 (FMO1) and 3 (FMO3) Developmental Expression

Koukouritaki, S. B., Simpson, P., Yeung, C. K., Rettie, A. E., & Hines, R. N. (2002) · Pediatric Research

Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

Cited by 245

A Chemical Category-Based Prioritization Approach for Selecting 75 Per- and Polyfluoroalkyl Substances (PFAS) for Tiered Toxicity and Toxicokinetic Testing

Patlewicz, G., Richard, A. M., Williams, A. J., Grulke, C. M., Sams, R., Lambert, J., Noyes, P. D., DeVito, M. J., Hines, R. N., Strynar, M., et al. (2019) · Environmental Health Perspectives

Per- and polyfluoroalkyl substances researchToxic Organic Pollutants Impact

Cited by 128

Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria

Cashman, J., Camp, K., Fakharzadeh, S., Fennessey, P., Hines, R., Mamer, O., Mitchell, S., Preti, G., Schlenk, D., & Smith, R. (2003) · Current Drug Metabolism

Pharmacogenetics and Drug MetabolismMetabolism and Genetic Disorders

Cited by 110